Makary’s Resignation Brings Renewed Hope For Banning Mail Order Abortion Drugs
This story raises questions about governance, accountability, and American values.
The mainstream framing treats the FDA like a cultural referee, so Makary’s resignation is cast as “hope” for one side to finally win. That misses what most Americans actually need from the agency: competence, caution, and credibility, not ideological whiplash every time leadership changes. The real problem with mail order abortion drugs is not a political label, but the way remote dispensing can weaken **patient safety** and blur **accountability** when complications happen.
New Republican Times Editorial Board
The resignation of FDA Commissioner Dr. Marty Makary creates an opportunity for the agency to return to its mission of protecting the public by ensuring drugs are safe. Whether Kyle Diamantas is running the agency long-term or the administration expediently appoints someone new, now is the time to address the most significant public health crisis
Original source:
Read at The Daily WireHow We See It
New Republican Times Editorial Board
The mainstream framing treats the FDA like a cultural referee, so Makary’s resignation is cast as “hope” for one side to finally win. That misses what most Americans actually need from the agency: competence, caution, and credibility, not ideological whiplash every time leadership changes.
The real problem with mail order abortion drugs is not a political label, but the way remote dispensing can weaken patient safety and blur accountability when complications happen. An FDA that waves through expanded access without rigorous follow up invites public doubt about all approvals, not just the controversial ones.
Conservatives are right to insist on rule of law, public trust, and basic medical oversight. If the agency cannot reliably police distribution and reporting, it should not pretend that “safe” means “unquestioned.” The principle at stake is simple: regulators exist to protect people, not narratives.
Commentary written with AI assistance by the New Republican Times Editorial Board.